Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-071374
Filing Date
2021-12-28
Accepted
2021-12-28 16:13:58
Documents
1
Period of Report
2021-12-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7183
  Complete submission text file 0001209191-21-071374.txt   8573
Mailing Address 3061 ZANKER RD SAN JOSE CA 95134
Business Address
GUGGENHIME ANDREW (Reporting) CIK: 0001230724 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39323 | Film No.: 211525110

Mailing Address 353 HATCH DR FOSTER CITY CA 94404
Business Address 353 HATCH DR FOSTER CITY CA 94404 650-837-0111
Vaxcyte, Inc. (Issuer) CIK: 0001649094 (see all company filings)

EIN.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)